39 CHEMICALS KNOWLEDGE HUB Issue 2 / October 2025 PROCOS In global supply chains, AI enhances transparency, real-time monitoring and ethical sourcing compliance. AI applications are also helping companies track emissions, reduce waste and optimise resource usage – key enablers for ESG success. For example, AI in pharmaceutical manufacturing can reduce material consumption, lower energy usage and streamline processes. Predictive analytics helps forecast disruptions and support decision-making aligned with sustainability objectives. However, integrating AI is not without challenges. Companies must overcome high implementation costs, ensure cross-border data standardisation and build new internal capabilities. Effective AIESG integration requires skilled employees, who understand both digital tools and sustainability principles. Upskilling, cross-functional collaboration and partnerships with academia and tech providers are essential for long-term success. AI also assists with ESG compliance amid increasingly complex regulations like GRI, SASB, the EU’s CSRD and the CSDDD. Automation helps gather, process and analyse large volumes of ESG data, reducing the burden of reporting and improving responsiveness to regulatory changes. Conclusion As we approach our 80th anniversary in 2025, PROCOS reaffirms its commitment to sustainability – not as a duty, but as a strategic advantage and a source of pride. From Lina Croci’s early contributions to our current ESG roadmap, we continue to uphold a culture of responsibility, collaboration and innovation. Whether through advanced technologies, inclusive policies or science-based climate actions, we remain dedicated to making a positive impact. At PROCOS, ESG is not a checkbox – it’s a compass guiding us toward a future where economic growth, social progress and environmental integrity go hand in hand. the community: we support educational and cultural initiatives, such as our partnership with Igor Volley, a top-tier women’s volleyball team that reflects our values of inclusion, excellence and empowerment. We collaborate with universities and schools to foster scientific education and offer internship programs that build the next generation of talent. We believe that by investing in people – both inside and outside our organisation – we strengthen our social impact. Governance A robust governance structure is essential to our sustainable growth. At PROCOS, our Business Continuity Plan (BCP) ensures resilience against disruptions – from global supply chain shocks to health emergencies – safeguarding not only operations, but also patient access to vital medicines. Our governance approach also includes strict adherence to international compliance and anticorruption standards. A cross-departmental ESG Team monitors strategic objectives and ensures progress, reinforcing our belief that sustainability is a shared responsibility. Business continuity’s role In the pharmaceutical sector, API production is a critical mission. Ensuring business continuity means maintaining consistent and reliable operations even in the face of disruptions. This directly impacts patient safety, operational stability and regulatory compliance. To guarantee continuity, API producers like PROCOS must develop resilient supply chains, robust risk management frameworks and strategic partnerships. Today’s partnerships are no longer transactional, they are collaborative. Pharma companies and CDMOs like ours now work together, combining expertise to co-develop innovative and flexible manufacturing strategies. Innovation plays a central role. Advances in HPAPIs, ADCs and cell and gene therapies are redefining the landscape. Technologies such as continuous manufacturing and AI-driven optimisation are enhancing both flexibility and compliance. Leveraging AI to boost ESG Emerging technologies, particularly AI, are revolutionising how ESG goals are achieved. SONIA RASI Financial Director & Chief Sustainability Officer PROCOS SpA
RkJQdWJsaXNoZXIy MjY2OTA4MA==